40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
237.14%
Some net income increase while EQT is negative at -34.15%. John Neff would see a short-term edge over the struggling competitor.
41.11%
Some D&A expansion while EQT is negative at -1.57%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
354.84%
Well above EQT's 2.16% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-136.96%
Negative yoy SBC while EQT is 46.59%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-62.71%
Both reduce yoy usage, with EQT at -74.17%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-132.76%
Both yoy AR lines negative, with EQT at -63.62%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.71%
Negative yoy usage while EQT is 20.27%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
51.02%
Some yoy increase while EQT is negative at -1432.22%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
71.27%
Some CFO growth while EQT is negative at -49.09%. John Neff would note a short-term liquidity lead over the competitor.
-1.90%
Both yoy lines negative, with EQT at -6.39%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-120.27%
Negative yoy acquisition while EQT stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-155.56%
Both yoy lines negative, with EQT at -34.72%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-30.76%
Both yoy lines negative, with EQT at -6.47%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2505.00%
Both yoy lines negative, with EQT at -27.99%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
-59.25%
We cut yoy buybacks while EQT is 96.07%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.